Match Document Document Title
US20120039969 SWELLABLE DOSAGE FORM COMPRISING GELLAN GUM  
A novel dosage form. The dosage form is presented in particulate form and before oral ingestion the particulate material is subjected to an aqueous medium, whereby it is converted to a semi-solid...
US20110236473 STABLE ALISKIREN FORMULATIONS  
An oral pharmaceutical formulation, made up of croscarmellose sodium and internal granules including a pharmaceutically acceptable salt or polymorph of aliskiren and stearic acid.
US20120276175 Personal Cleansing Compositions with Increased Deposition of Polyacrylate Microcapsules  
A personal cleansing composition that increases the deposition and retention of benefit agent containing polyacrylate microcapsules onto hair and/or skin. The personal cleansing composition is...
US20140294944 MICROENCAPSULATION OF OXYGEN LIBERATING REACTANTS  
There is provided a composition for the delivery of oxygen having microencapsulated peroxide and microencapsulated catalyst that liberate oxygen upon sufficient contact with each. The components...
US20140234217 REMOTE ASSEMBLY OF TARGETED NANOPARTICLES USING COMPLEMENTARY OLIGONUCLEOTIDE LINKERS  
The present invention provides targeted delivery compositions and their methods of use in treating and diagnosing a disease state in a subject. Components of the targeted delivery compositions are...
US20120058180 Liver-specific Nanocapsules and Methods of Using  
This disclosure describes liver-specific nanocapsules for specifically targeting liver cells. This disclosure also provides methods of using such liver-specific nanocapsules to deliver one or more...
US20130337057 NOVEL HERBAL COMPOSITION FOR THE TREATMENT OF KIDNEY STONE AND OTHER URINARY TRACT DISORDERS  
Discloses a novel synergistic herbal composition comprising combination of therapeutically effective amount of Vrun bhavit, Kadalikshar, Apamargkshar, Yavkshar and optionally Gomutrakshar along...
US20150216806 LAXATIVE COMPOSITIONS AND METHODS FOR TREATING CONSTIPATION AND RELATED GASTROINTESTINAL DISEASES AND CONDITIONS  
In alternative embodiments, the invention provides compositions, e.g., formulations or preparations, used for treating, ameliorating or preventing constipation and other disorders with related...
US20110097385 Delivery System for Drug and Cell Therapy  
A method of lowering blood glucose in a mammal includes administering orally or by injection or inhalation a therapeutically effective amount of crystallized dextran microparticles and insulin to...
US20130095157 COSMETIC COMPOSITION CONTAINING RETINOL STABILIZED BY POROUS POLYMER BEADS AND NANOEMULSION  
The present invention relates to a method for stabilizing retinol (Vitamin A), an unstable fat-soluble material, to use the same in cosmetics. The present invention provides an anti-inflammatory...
US20060147516 Taste masking system for alprazolam  
The present invention relates to taste masking system, taste masked formulations, dosage forms made from those formulations and methods of making those formulations that involve dissolving or...
US20140287032 Treatment Method and Product for Uterine Fibroids using Purified Collagenase  
The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of...
US20110104265 COMPOSITIONS AND METHODS OF TARGETED NANOFORMULATIONS IN THE MANAGEMENT OF OSTEOPOROSIS  
A composition and method for treating a bone condition of an animal. The compostion includes nanoparticles; a targeted moiety covalently bonded to an outer surface of each nanoparticle; and...
US20130183380 Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-yl)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate  
Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxa mide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are...
US20140220119 Capsules Containing High Doses of Levodopa for Pulmonary Use  
The present invention provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC)...
US20130011470 PHARMACEUTICAL FORMULATIONS OF NAPROXEN FOR SOFT GEL ENCAPSULATION AND COMBINATIONS THEREOF  
An NSAID formulation for encapsulation into a soft gel capsule with increased stability, concentration and bioavailability of the NSAID. The preferred NSAIDS are naproxen, ibprofen, indomethacin...
US20140234408 BEVERAGE COMPOSITIONS AND OTHER FORMULATIONS FOR TREATING ALLERGIES AND METHODS FOR MAKING THE SAME  
A composition for preventing and/or alleviating an allergy related condition and methods of making such compositions are disclosed herein. A composition in accordance with a particular embodiment...
US20110244032 DISPERSIBLE PHOSPHOLIPID STABILIZED MICROPARTICLES  
Rapidly dispersing solid dry therapeutic dosage form comprised of a water insoluble compound existing as a nanometer or micrometer particulate solid which is surface stabilized by the presence of...
US20110195116 RATE MODULATED DELIVERY OF DRUGS FROM A COMPOSITE DELIVERY SYSTEM  
This invention relates to a pharmaceutical dosage form for the delivery of at least one active pharmaceutical ingredient (API) or the pharmaceutically active salts and isomers thereof, to a...
US20050175685 Universal pet medication and capsule system  
A pet medication capsule is of uniform cylindrical form, closed at one end and open at an opposing end. The capsule is made of an edible product attractive to an animal and has a length of between...
US20130171252 Formulation Comprising a Type B Lantibiotic  
Described is a pharmaceutical formulation of a capsule for oral delivery of a type B lantibiotic to the stomach comprising a hard gelatine, HPMC or starch capsule, and a type B lantibiotic of...
US20110104266 MULTIMICROPARTICULATE PHARMACEUTICAL FORMS FOR ORAL ADMINISTRATION  
The object of the present invention is to minimize the risks of dose dumping associated with the concomitant consumption of alcohol and certain modified-release pharmaceutical or dietetic forms....
US20110086089 USE OF P27KIP1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE  
p27KIP1 (p27) blocks cell proliferation through inhibition of FIG. 6 cyclin-dependent kinase 2 (dk2)1. Despite its robust expression in the heart2,3, little is known about both the function and...
US20140134241 TCR Mimic Antibodies as Vascular Targeting Tools  
The present invention includes a method of delivering a therapeutic agent into and across an endothelial cell (EC) in a subject in need thereof, comprising: identifying a subject in need for...
US20110059164 ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS  
An encapsulated material containing an oxidation-sensitive core is covered by at least a dried synthetic organelle layer and optional additional ingredients in the organelle layer or additional...
US20110142925 Film Coating For Tablets And Caplets  
The present invention relates to novel coating compositions for application to solid dosage forms such as tablets or caplets, solid dosage forms coated with the composition, and methods of...
US20140363496 Compositions and Methods for Inducing Nanoparticle-mediated Microvascular Embolization of Tumors  
Nanoparticle mediated microvascular embolization (NME) of tumor tissue may occur after systemic administration of PEM, leading to widespread shutdown of vascular flow, hemorrhage, and necrosis....
US20110123604 ABSORBENT POLYMERIC COMPOSITIONS WITH VARYING COUNTERION CONTENT AND THEIR METHODS OF PREPARATION AND USE  
Cross-linked polyelectrolyte polymers with bound counterions that absorb about 20-fold or more of their mass in saline such as physiological saline a with the proviso that sodium does not exceed...
US20130337054 TREATMENT OF EXCESSIVE MENSTRUAL BLOOD LOSS BY INTRAVAGINAL ADMINISTRATION OF LOW DOSES OF ANTIFIBRINOLYTIC OR HEMOSTATIC AGENT  
A method and drug delivery device for reducing menstrual blood loss in a female are provided. The method comprises administering intravaginally to the female a therapeutically effective amount of...
US20130295168 Oral Drug Delivery System  
Dosage forms and drug delivery devices suitable for administration of pharmaceutical compounds and compositions, including the oral drug administration of compounds.
US20130287845 Oral Drug Delivery System  
Dosage forms and drug delivery devices suitable for administration of pharmaceutical compounds and compositions, including the oral drug administration of compounds.
US20120135073 Oral Drug Delivery System  
Dosage forms and drug delivery devices suitable for administration of pharmaceutical compounds and compositions, including the oral drug administration of compounds.
US20120135072 Oral Drug Delivery System  
Dosage forms and drug delivery devices suitable for administration of pharmaceutical compounds and compositions, including the oral drug administration of compounds.
US20100233253 EXTENDED RELEASE GASTRO-RETENTIVE ORAL DRUG DELIVERY SYSTEM FOR VALSARTAN  
An extended release gastro-retentive drug delivery system of Valsartan. The drug delivery system contains a release portion containing the Valsartan, a gastro-retentive portion for retaining the...
US20120269887 POMEGRANATE FRUIT POLYPHENOL COMPOSITION AND METHODS OF USE AND MANUFACTURE THEREOF  
A pharmaceutical composition with an active pharmaceutical ingredient including a pomegranate fruit polyphenol extract. The pomegranate fruit polyphenol extract includes at least about 3% combined...
US20140341987 COLOUR CHANGING COMPOSITION IN O/W EMULSION FORM  
A changing colour composition for caring for and/or making up keratin materials on the form of an O/W emulsion comprising, in a physiologically acceptable medium, at least a) microcapsules...
US20120027848 Enzyme Delivery Systems and Methods of Preparation and Use  
This invention relates to coated digestive enzyme preparations and enzyme delivery systems and pharmaceutical compositions comprising the preparations. This invention further relates to methods of...
US20140341954 STABLE EMULSIONS VIA PARTICLE ABSORPTION BY ELECTROSTATIC INTERACTION  
Disclosed are methods of preparing stable O/W emulsions by particle adsorption via electrostatic interaction, and stable emulsions prepared by particle adsorption via electrostatic interaction....
US20140093561 ORAL DOSAGE FORMS OF CYCLOPROPANECARBOXYLIC ACID -AMIDE  
Provided herein are controlled release oral dosage forms of poorly soluble drugs, methods of making the dosage forms, and methods of their use for the treatment of various diseases and/or disorders.
US20140170211 COMPOSITIONS AND METHODS FOR TREATING TRAUMATIC BRAIN INJURY  
The disclosure provides compositions treating traumatic brain injuries such as concussions. In one embodiment, the composition comprises phosphatidylserine, phosphatidylcholine, quercetin,...
US20110300208 SEGMENTED PHARMACEUTICAL DOSAGE FORMS  
A pharmaceutical tablet adapted for accurate division of a dose of a drug into two or more smaller doses, which tablet has two or more segments.
US20110256216 Probiotic Confection and Lipid Compositions  
The present application relates to probiotic confection-based compositions comprising lactic acid-producing bacteria and oil-based compositions comprising the same.
US20150004222 METHODS FOR PREPARING CELL DELIVERY MATRICES  
Cell delivery matrices and methods for facilitating local delivery of adipose derived endothelial cells to a target tissue, body cavity, or joint are described. The cell delivery matrix may be a...
US20060083783 Treating metabolic syndrome with fenofibrate  
A method of treating metabolic syndrome in a human diagnosed with metabolic syndrome by administering a therapeutically effective amount of fenofibrate over a treatment period. The results can...
US20110097393 Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery  
This invention relates to a sustained release oral and transdermal pharmaceutical formulations and delivery systems comprising lofexidine. The invention is also directed to methods of treatment...
US20120308653 WORMWOOD PILL CONTAINING 95% OF WORMWOOD ETHYL ALCOHOL EXTRACT THAT HAS INACTIVATION EFFICACY OF THE H1N1 VIRUS AND THE H9N2 AVIAN INFLUENZA VIRUS  
A mugwort pill containing a 95% ethanol extract of wormwood having an inactivation power with respect to a novel swine-origin influenza virus and an avian influenza virus is disclosed. In more...
US20140348910 Topical Formulations Including Lipid Microcapsule Delivery Vehicles and Their Uses  
The present invention relates to topical formulations that include lipid microcapsules formed from tocopherol, tocotrienol, or mixtures thereof; a stabilizer/surfactant component; and an aqueous...
US20110142926 Nanoparticles for protein drug delivery  
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one antibiotics or equivalent bioactive agent characterized with a positive surface charge and...
US20130236538 PHARMACEUTICAL COMPOSITIONS OF IBUPROFEN AND FAMOTIDINE  
Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. In some embodiments, the ibuprofen is in direct physical contact with the famotidine.
US20130017255 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent  
Pharmaceutical compositions and dosage forms comprising an adsorbent, and an adverse agent, such as an opioid antagonist. In one embodiment, at least a portion of the adverse agent is on the...